Browsing: Pharmaceuticals
6 months ago
Amgen Beats Biocon to Market with Eylea Biosimilar, Impacting Biocon’s Outlook
Alembic Pharma Secures USFDA Final Approval for Diltiazem Hydrochloride Extended-Release Capsules (120 mg, 180 mg, 240 mg) with $28.2M Market Potential
Fermenta Biotech to Divest Mumbai Office Space for ₹40 Crore